STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)

NCT00124332 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

839

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Atherosclerosis

Interventions

DRUG: Rimonabant (SR141716)
DRUG: Placebo

Sponsor

Sanofi